Related Experiment Video
Updated: May 21, 2026

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
Published on: February 26, 2021
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
Jung-Tung Liu1, Yuh-Lien Chen, Wen-Chi Chen
1Department of Neurosurgery, School of Medicine, Chung-Shan Medical University and Hospital, Taichung 402, Taiwan.
Insights
Pigment epithelium-derived factor (PEDF) is a potent endogenous inhibitor of stem cell neovascularization. This review highlights PEDF
Area of Science:
- Biochemistry
- Molecular Biology
- Ophthalmology
Background:
- Pigment epithelium-derived factor (PEDF) is an endogenous protein with diverse biological activities.
- PEDF is widely expressed in various human tissues, including the eyes, liver, heart, and adipose tissue.
- It possesses antiangiogenic, antitumorigenic, antioxidant, anti-inflammatory, antithrombotic, neurotrophic, and neuroprotective properties.
Purpose of the Study:
- To review the significance of PEDF as an endogenous antiangiogenic molecule.
- To focus on PEDF's recently identified role in inhibiting stem/progenitor cell-associated neovascularization.
- To explore PEDF as a potential therapeutic target for diseases involving neovascularization.
Main Methods:
- Literature review of studies on Pigment epithelium-derived factor (PEDF).
- Analysis of PEDF's biological activities and expression patterns.
- Examination of PEDF's role in neovascularization and related diseases.
Main Results:
- PEDF is identified as the most potent inhibitor of stem/progenitor cell-associated neovascularization.
- PEDF plays a role in the pathogenesis of angiogenic eye disease, tumor growth, and cardiovascular disease.
- Novel antiangiogenic agents are needed for treating various diseases.
Conclusions:
- PEDF is a crucial endogenous antiangiogenic factor.
- PEDF's inhibition of stem/progenitor cell neovascularization presents a promising therapeutic target.
- Further research into PEDF could lead to novel treatments for angiogenic diseases.
Abstract:
Pigment epithelium-derived factor (PEDF) was first identified in retinal pigment epithelium cells. It is an endogenously produced protein that is widely expressed throughout the human body such as in the eyes, liver, heart, and adipose tissue; it exhibits multiple and varied biological activities. PEDF is a multifunctional protein with antiangiogenic, antitumorigenic, antioxidant, anti-inflammatory, antithrombotic, neurotrophic, and neuroprotective properties. More recently, PEDF has been shown to be the most potent inhibitor of stem/progenitor cell-associated neovascularization. Neovascularization is a complex process regulated by a large, interacting network of molecules from stem/progenitor cells. PEDF is also involved in the pathogenesis of angiogenic eye disease, tumor growth, and cardiovascular disease. Novel antiangiogenic agents with tolerable side effects are desired for the treatment of patients with various diseases. Here, we review the value of PEDF as an important endogenous antiangiogenic molecule; we focus on the recently identified role of PEDF as a possible new target molecule to influence stem/progenitor cell-related neovascularization.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Mechanism of Angiogenesis
Regulation of Hematopoietic Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Stem Cell Niche

